Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA

NCT01204138 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped decision of sponsor to withdraw before initiation; 0 patients enrolled

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Apremilast
DRUG: Placebo

Sponsor

Stanford University

Collaborators

[object Object]